Local Anesthetics — MCQs

Local Anesthetics Indian Medical PG Practice Questions and MCQs

Question 101: Which of the following local anesthetic agents, when used with epinephrine, provides long-duration anesthesia?

A. 2% Lidocaine HCl + Epinephrine 1:200,000
B. 3% Mepivacaine HCl
C. 4% Prilocaine HCl + Epinephrine 1:200,000
D. 0.5% Bupivacaine + Epinephrine 1:200,000 (Correct Answer)

Explanation: **Explanation:** The duration of action of a local anesthetic (LA) is primarily determined by its **protein binding capacity**. Agents with high protein binding remain at the receptor site in the nerve membrane for a longer period. **Why D is correct:** **Bupivacaine** is a potent, long-acting amide local anesthetic with very high protein binding (approx. 95%). While it is inherently long-acting, the addition of **Epinephrine (1:200,000)** acts as a vasoconstrictor. This reduces regional blood flow, slowing the systemic absorption of the drug and further prolonging its local analgesic effect. It typically provides anesthesia for 4–8 hours, making it the gold standard for long-duration procedures and postoperative pain management. **Why other options are incorrect:** * **A. 2% Lidocaine:** This is an intermediate-acting agent. Even with epinephrine, its duration is significantly shorter (approx. 2–3 hours) than Bupivacaine. * **B. 3% Mepivacaine:** This is an intermediate-acting agent. It lacks significant vasodilator properties (unlike lidocaine), but its protein binding is lower than bupivacaine, resulting in a shorter duration. * **C. 4% Prilocaine:** Also an intermediate-acting agent. It is metabolized to ortho-toluidine, which can cause methemoglobinemia in high doses. **High-Yield Clinical Pearls for NEET-PG:** * **Potency** is determined by **Lipid Solubility**. * **Duration of Action** is determined by **Protein Binding**. * **Onset of Action** is determined by **pKa** (Lower pKa = Faster onset). * **Bupivacaine Toxicity:** It is highly cardiotoxic (blocks sodium channels in the heart). The treatment of choice for Bupivacaine-induced systemic toxicity (LAST) is **20% Intralipid emulsion**. * **Epinephrine Contraindication:** Never use epinephrine-containing LAs in "end-artery" areas (fingers, toes, nose, penis, pinna) due to the risk of gangrene.

Question 102: Which local anesthetic is known for its differential blockade properties, making it a preferred choice or a differential block option?

A. Lignocaine
B. Ropivacaine (Correct Answer)
C. Bupivacaine
D. Dibucaine

Explanation: ### Explanation **Concept of Differential Blockade** Differential blockade refers to the ability of a local anesthetic to selectively block sensory nerve fibers (pain) while sparing motor nerve fibers. This is highly desirable in obstetric analgesia (painless labor) and postoperative pain management, as it allows patients to remain mobile while being pain-free. **Why Ropivacaine is the Correct Answer** Ropivacaine, an amino-amide local anesthetic and the pure S-enantiomer of bupivacaine, is the drug of choice for differential blockade. It is less lipophilic than bupivacaine, which makes it less likely to penetrate the large, myelinated A-alpha motor fibers. Consequently, at lower concentrations (e.g., 0.2%), it provides excellent sensory analgesia with minimal motor impairment. Additionally, it has a higher threshold for cardiotoxicity compared to bupivacaine. **Analysis of Incorrect Options** * **A. Lignocaine:** Known for its rapid onset and intermediate duration. It produces a dense, non-selective block where motor and sensory fibers are affected almost simultaneously. * **C. Bupivacaine:** While it also exhibits some differential block, it is significantly less selective than ropivacaine. It carries a higher risk of cardiotoxicity (due to slow dissociation from sodium channels). * **D. Dibucaine:** An amino-ester anesthetic primarily used for its "Dibucaine Number" to test for atypical pseudocholinesterase deficiency; it is not used for differential blockade in clinical practice. **High-Yield Clinical Pearls for NEET-PG** * **Cardiotoxicity:** Ropivacaine is safer than Bupivacaine because it dissociates faster from cardiac sodium channels. * **Vasoconstriction:** Unlike most local anesthetics (which are vasodilators), Ropivacaine has inherent vasoconstrictive properties. * **S-Enantiomers:** Both Ropivacaine and Levobupivacaine are pure S-enantiomers, designed to reduce the systemic toxicity associated with the racemic mixtures.

Question 103: What is the maximum recommended dose of lignocaine with adrenaline in mg/kg?

A. 4
B. 5
C. 7 (Correct Answer)
D. 10

Explanation: **Explanation:** The maximum recommended dose of Lignocaine (Lidocaine) is determined by its systemic toxicity profile. The addition of **adrenaline (epinephrine)**, typically in a 1:200,000 concentration, causes local vasoconstriction. This slows the systemic absorption of the anesthetic, prolonging its duration of action and allowing for a higher safe dosage threshold. * **Correct Answer (C - 7 mg/kg):** For Lignocaine **with** adrenaline, the maximum safe dose is **7 mg/kg**. This is a high-yield value frequently tested in NEET-PG. * **Option B (5 mg/kg):** This is the maximum recommended dose for Lignocaine **plain** (without adrenaline). Exceeding this increases the risk of Local Anesthetic Systemic Toxicity (LAST). * **Option A (4 mg/kg):** This is below the standard safe limit for Lignocaine but is closer to the maximum dose for Bupivacaine (2-3 mg/kg). * **Option D (10 mg/kg):** This exceeds the safety margin for Lignocaine and would likely result in CNS or cardiovascular toxicity. **High-Yield Clinical Pearls for NEET-PG:** 1. **Absolute Max Dose:** Regardless of weight, the total dose of Lignocaine with adrenaline should generally not exceed **500 mg**. 2. **Bupivacaine Limits:** Plain = 2 mg/kg; with adrenaline = 3 mg/kg. 3. **Toxicity Sequence:** CNS symptoms (perioral numbness, metallic taste, seizures) usually precede Cardiovascular Collapse (CVC) with Lignocaine. 4. **Antidote:** Intravenous **Lipid Emulsion (20% Intralipid)** is the specific treatment for LAST.

Question 104: On the administration of local anesthetic in an area of infection, what is the predominant form of the local anesthetic?

A. Increased cationic form (Correct Answer)
B. Buffering capacity of the local anesthetic is decreased
C. Decreased concentration of the uncharged base
D. Decreased concentration of charged cations

Explanation: ### Explanation Local anesthetics (LAs) are **weak bases**, typically prepared as water-soluble hydrochloride salts. In the body, they exist in a chemical equilibrium between two forms: the **uncharged lipid-soluble base (B)** and the **charged water-soluble cation (BH⁺)**. **1. Why "Increased cationic form" is correct:** The pKa of most local anesthetics ranges from 7.7 to 9.1. According to the Henderson-Hasselbalch equation, the ratio of base to cation depends on the pH of the tissue. **Infected tissues are acidic (low pH)** due to the accumulation of lactic acid and inflammatory mediators. In an acidic environment, the equilibrium shifts to the left ($H^+ + B \rightleftharpoons BH^+$), resulting in a significantly **increased concentration of the ionized (cationic) form**. Since only the uncharged base can diffuse across the lipid nerve membrane, the anesthetic action is delayed or ineffective in infected areas. **2. Analysis of Incorrect Options:** * **Option B:** The buffering capacity of the tissue (not the LA) is overwhelmed by the infection, but this is a physiological consequence, not the description of the LA's state. * **Option C:** While it is true that the concentration of the uncharged base decreases, the question asks for the **predominant form**. In an acidic medium, the cationic form becomes the dominant species. * **Option D:** This is the opposite of what occurs; the concentration of charged cations increases. **3. NEET-PG High-Yield Pearls:** * **Mechanism of Action:** The **uncharged base** crosses the nerve membrane, but the **charged cation** actually binds to the internal receptor of the voltage-gated sodium channel to block conduction. * **pKa and Onset:** The closer the pKa of a drug is to the tissue pH (7.4), the faster the onset of action (e.g., Lidocaine pKa 7.9 vs. Bupivacaine pKa 8.1). * **Alkalinization:** Adding Sodium Bicarbonate to LA increases the non-ionized form, speeding up the onset of the block and reducing pain on injection.

Question 105: Which of the following local anesthetics should not be mixed with adrenaline?

A. Lignocaine
B. Bupivacaine
C. Mepivacaine
D. Cocaine (Correct Answer)

Explanation: **Explanation:** **1. Why Cocaine is the Correct Answer:** Cocaine is unique among local anesthetics because it possesses intrinsic **sympathomimetic activity**. It works by blocking the reuptake of norepinephrine at sympathetic nerve endings, leading to intense vasoconstriction and tachycardia. Adding adrenaline (epinephrine) to cocaine would result in a synergistic effect, causing dangerous levels of vasoconstriction, severe hypertension, and potentially fatal cardiac arrhythmias or myocardial ischemia. Therefore, it is the only local anesthetic where the addition of adrenaline is strictly contraindicated. **2. Why Other Options are Incorrect:** * **Lignocaine & Bupivacaine:** These are the most common local anesthetics used with adrenaline. Since they are vasodilators, adrenaline is added to provide local vasoconstriction, which decreases systemic absorption (reducing toxicity), prolongs the duration of action, and provides a bloodless surgical field. * **Mepivacaine:** While mepivacaine has mild intrinsic vasoconstrictive properties compared to lignocaine, it is still frequently and safely combined with adrenaline to enhance its clinical profile. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Cocaine is an ester-type anesthetic; all others in the options are amides (except cocaine). * **Ester vs. Amide:** Remember the "i" rule—Amides have two "i"s in their name (L**i**doca**i**ne, Bup**i**vaca**i**ne), while Esters have only one (Coca**i**ne, Proca**i**ne). * **Adrenaline Concentration:** The standard concentration used with local anesthetics is **1:200,000**. * **Contraindication Sites:** Never use adrenaline-containing local anesthetics in "end-artery" areas (fingers, toes, nose, ears, and penis) due to the risk of gangrene.

Question 106: Which of the following local anesthetics does not require the addition of adrenaline?

A. Procaine
B. Lignocaine
C. Bupivacaine
D. Cocaine (Correct Answer)

Explanation: **Explanation:** The correct answer is **Cocaine**. The fundamental pharmacological principle here is the effect of local anesthetics (LAs) on blood vessel diameter. **1. Why Cocaine is the Correct Answer:** Most local anesthetics are **vasodilators**. However, Cocaine is unique because it is the only local anesthetic that possesses significant **intrinsic vasoconstrictive properties**. It achieves this by inhibiting the reuptake of norepinephrine at sympathetic nerve endings. This leads to increased levels of norepinephrine in the synaptic cleft, causing localized vasoconstriction. Therefore, adding adrenaline (epinephrine) is unnecessary and potentially dangerous, as it could lead to severe hypertension or tissue necrosis. **2. Why the Other Options are Incorrect:** * **Procaine (Option A):** A short-acting ester LA with potent vasodilatory effects. Without adrenaline, it is rapidly absorbed into the systemic circulation, leading to a very short duration of action and higher risk of toxicity. * **Lignocaine (Option B):** The most commonly used amide LA. It causes significant vasodilation. Adrenaline is routinely added (1:200,000) to prolong its duration, decrease systemic absorption, and provide a bloodless surgical field. * **Bupivacaine (Option C):** A long-acting amide LA. While it has a longer duration than Lignocaine, it still causes vasodilation. Adrenaline is often added to further extend its block and reduce peak plasma concentrations. **3. Clinical Pearls for NEET-PG:** * **Vasoconstriction Exception:** While Cocaine is the primary vasoconstrictor, **Ropivacaine** also has mild intrinsic vasoconstrictive properties, though it is not as potent as Cocaine. * **Adrenaline Contraindications:** Never use adrenaline-containing LAs in "end-artery" areas (fingers, toes, tip of the nose, ears, and penis) to avoid ischemic necrosis. * **Maximum Dose:** Adding adrenaline increases the maximum permissible dose of Lignocaine from **3 mg/kg to 7 mg/kg**.

Question 107: What is the cause of the sensation of tissue tearing during the administration of local anesthesia?

A. Passage through a cyst
B. Passage through a muscle
C. Passage through an area of infection
D. Barb on the needle (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. Barb on the needle** The sensation of "tissue tearing" or "dragging" during the insertion or withdrawal of a needle is a classic clinical sign of a **barbed needle**. A barb is a microscopic hook at the tip of the needle, usually caused by the needle tip striking bone during a previous injection attempt or accidental contact with a hard surface. As the needle moves through the tissues, this hook catches and tears the connective tissue fibers, causing both the characteristic sensation for the clinician and significant post-operative pain or trismus for the patient. **Analysis of Incorrect Options:** * **A. Passage through a cyst:** This typically results in a "loss of resistance" or a sudden "pop" followed by ease of flow, rather than a tearing sensation. * **B. Passage through a muscle:** Muscle penetration usually offers steady, firm resistance. While it may cause discomfort, it does not produce a tactile tearing sensation unless the needle is damaged. * **C. Passage through an area of infection:** Infected tissues are often more vascular and edematous (acidic environment). Injection here is usually associated with intense burning pain due to the pH shift and increased pressure, but not a mechanical tearing sensation. **High-Yield NEET-PG Pearls:** * **Prevention:** Always discard a needle after it has touched bone or if it has been used for more than 3–4 penetrations in the same patient. * **Safety Check:** To check for a barb before injection, draw the needle backward across a sterile gauze pad; if it snags the fibers, the needle is barbed and must be replaced. * **Complication:** Using a barbed needle significantly increases the risk of **needle breakage**, a rare but serious complication in regional anesthesia.

Question 108: What is the maximum dose of lignocaine without adrenaline that can be administered to a patient?

A. 4 mg/kg body weight (Correct Answer)
B. 5 mg/kg body weight
C. 7 mg/kg body weight
D. 9 mg/kg body weight

Explanation: **Explanation:** Lignocaine (Lidocaine) is an amide-linked local anesthetic that acts by blocking voltage-gated sodium channels. The maximum safe dose is determined by the risk of **Systemic Toxicity (LAST)**, which occurs when plasma levels rise due to excessive administration or accidental intravascular injection. 1. **Why Option A is Correct:** For **plain lignocaine (without adrenaline)**, the maximum recommended dose is **3–4 mg/kg body weight**. This limit is set to prevent CNS side effects (like seizures) and cardiovascular collapse. In a standard 70 kg adult, this equates to approximately 200–280 mg. 2. **Why Option C is Incorrect:** **7 mg/kg** is the maximum dose for **lignocaine with adrenaline (1:200,000)**. Adrenaline acts as a vasoconstrictor, slowing systemic absorption, prolonging the duration of action, and reducing peak plasma levels, thereby allowing a higher dose to be administered safely. 3. **Why Options B and D are Incorrect:** These values do not correspond to standard safety guidelines for lignocaine. 5 mg/kg is sometimes cited in older texts but is generally considered less conservative than 4 mg/kg in modern practice. 9 mg/kg exceeds the safety threshold for both plain and adrenaline-combined lignocaine. **High-Yield Clinical Pearls for NEET-PG:** * **Bupivacaine:** Max dose is **2 mg/kg** (plain) and **3 mg/kg** (with adrenaline). It is significantly more cardiotoxic than lignocaine. * **Treatment of Toxicity:** Intravenous **Lipid Emulsion (20% Intralipid)** is the specific antidote for Local Anesthetic Systemic Toxicity (LAST). * **Order of Blockade:** Autonomic fibers > Pain/Temperature (A-delta & C) > Touch/Pressure > Motor. * **Metabolism:** Amides (like Lignocaine) are metabolized in the **liver** (P450 system), whereas Esters (like Procaine) are metabolized by **plasma pseudocholinesterase**.

Question 109: All of the following statements about lignocaine are true EXCEPT?

A. It blocks active sodium channels with more affinity than resting sodium channels.
B. It can cause cardiotoxicity.
C. It is given orally for the treatment of cardiac arrhythmias. (Correct Answer)
D. Adrenaline increases the duration of action of lignocaine when used for infiltration anesthesia.

Explanation: ### Explanation **Why Option C is the Correct Answer (The False Statement):** Lignocaine (Lidocaine) is a Class Ib anti-arrhythmic agent. However, it is **never administered orally** for the treatment of cardiac arrhythmias because it undergoes **extensive first-pass metabolism** in the liver (bioavailability <35%). For systemic effects, such as treating ventricular arrhythmias post-myocardial infarction, it must be administered intravenously. **Analysis of Other Options:** * **Option A:** Lignocaine follows the **"use-dependent" or "state-dependent" block** principle. It has a higher affinity for sodium channels in their **activated (open) or inactivated states** rather than the resting state. This is why it is more effective in rapidly firing tissues (like tachyarrhythmias or active pain fibers). * **Option B:** While lignocaine is less cardiotoxic than Bupivacaine, it can still cause **cardiotoxicity** at high plasma concentrations, leading to hypotension, bradycardia, and potentially cardiac arrest. * **Option C:** **Adrenaline (Epinephrine)** is a vasoconstrictor. When added to lignocaine for infiltration, it reduces local blood flow, thereby slowing systemic absorption. This **prolongs the duration of action**, reduces systemic toxicity, and provides a bloodless surgical field. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolism:** Lignocaine is metabolized in the liver by **CYP1A2** and **CYP3A4** into active metabolites (MEGX and glycine xylidide). * **Toxicity Sequence:** CNS symptoms (perioral numbness, metallic taste, seizures) usually precede Cardiovascular symptoms. * **Maximum Dose:** * Plain Lignocaine: **4.5 mg/kg** * Lignocaine with Adrenaline: **7 mg/kg** * **Drug of Choice:** Lignocaine is the drug of choice for **ventricular arrhythmias** occurring during cardiac surgery or post-MI.

Question 110: Which of the following is a long-acting local anesthetic?

A. Procaine
B. Lidocaine
C. Bupivacaine (Correct Answer)
D. Etidocaine

Explanation: **Explanation:** Local anesthetics (LAs) are classified based on their duration of action, which is primarily determined by their **lipid solubility** and **protein binding** capacity. Drugs with high protein binding (like Bupivacaine) remain at the receptor site longer, resulting in a prolonged duration of action. **1. Why Bupivacaine is Correct:** Bupivacaine is a potent, **long-acting** amide local anesthetic. It has high lipid solubility and approximately 95% protein binding. It provides anesthesia for 3–6 hours (or longer with epinephrine), making it ideal for labor analgesia (epidural) and post-operative pain management. **2. Analysis of Incorrect Options:** * **Procaine (Option A):** An ester-linked LA with low lipid solubility and low protein binding. It is a **short-acting** agent (30–60 minutes) and is rarely used today due to its high metabolic rate by plasma pseudocholinesterase. * **Lidocaine (Option B):** The "gold standard" amide LA. It is classified as an **intermediate-acting** agent (60–120 minutes). It is the most commonly used LA for infiltration and surface anesthesia. * **Etidocaine (Option D):** While Etidocaine is also a long-acting agent, Bupivacaine is the more clinically significant and frequently tested "long-acting" prototype in the NEET-PG context. (Note: In some classifications, both are long-acting, but Bupivacaine is the classic answer for its specific use in "differential block"). **High-Yield Clinical Pearls for NEET-PG:** * **Cardiotoxicity:** Bupivacaine is the most cardiotoxic LA. It binds tightly to sodium channels during diastole ("fast-in, slow-out" kinetics). **Intralipid (20%)** is the antidote for Bupivacaine-induced systemic toxicity (LAST). * **Differential Block:** Bupivacaine is unique because it can produce sensory blockade without significant motor blockade at low concentrations (0.125%), making it the drug of choice for **painless labor**. * **Ropivacaine:** A newer long-acting S-enantiomer of bupivacaine that is less cardiotoxic.

Practice by Chapter

Chemistry and Mechanism of Action

Practice Questions

Pharmacokinetics of Local Anesthetics

Practice Questions

Amide Local Anesthetics

Practice Questions

Ester Local Anesthetics

Practice Questions

Clinical Uses of Local Anesthetics

Practice Questions

Toxicity of Local Anesthetics

Practice Questions

Management of Local Anesthetic Systemic Toxicity

Practice Questions

Adjuvants to Local Anesthetics

Practice Questions

Maximum Safe Doses

Practice Questions

Local Anesthetics in Special Populations

Practice Questions

Allergic Reactions to Local Anesthetics

Practice Questions

Future Developments in Local Anesthetics

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free